Lilly drug slows Alzheimer's progression by 35% in trial &#x

Shares climb after company says drug met all primary and secondary goals of the trial

Related Keywords

Ireland , United States , Americans , Eli Lilly , Eric Reiman , Anne White , Reuters , Alzheimer Association , Banner Alzheimer Institute , Leqembi Phase , Banner Alzheimer , Lilly Neuroscience ,